Enasidenib Mesylate and Insulin Aspart (Vials)
Determining the interaction of Enasidenib Mesylate and Insulin Aspart (Vials) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: enasidenib
Brand name: Idhifa, Idhifa
Synonyms: Enasidenib
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Enasidenib Mesylate-Insulin Aspart (Vials) (Fiasp)
- Enasidenib Mesylate-Insulin aspart and insulin aspart protamine
- Enasidenib Mesylate-Insulin aspart and insulin degludec Subcutaneous
- Enasidenib Mesylate-Insulin Aspart Injection
- Enasidenib Mesylate-Insulin Aspart Protamine and Insulin Aspart
- Enasidenib Mesylate-Insulin aspart protamine and insulin aspart Subcutaneous
- Insulin Aspart (Vials)-EnBrace HR
- Insulin Aspart (Vials)-Enbrel
- Insulin Aspart (Vials)-Enbrel (Etanercept Prefilled Syringes)
- Insulin Aspart (Vials)-Enbrel (Etanercept Vials)
- Insulin Aspart (Vials)-Enbrel SureClick
- Insulin Aspart (Vials)-Encora